Halozyme to Acquire Elektrofi for Drug Delivery Expansion
October 1, 2025
Halozyme Therapeutics, Inc. announced that it has entered into a final agreement to purchase Elektrofi, Inc., a biopharmaceutical company that develops a revolutionary ultra-high concentration